Boesger Hannah, Williams Kurtis, Abdullai Sa Adatu, Hubble Brianna, Noori Mahboubeh S, Orac Crina, Amesaki Deborah K, Ghazanfari Davoud, Fairchild Emily A, Fatunbi Opeyemi O, Pritchard Joshua A, Goetz Douglas J, Hines Jennifer V, Bergmeier Stephen C
Department of Chemistry & Biochemistry, Ohio University, Athens, OH 45701, USA.
Department of Chemical and Biomolecular Engineering, Ohio University, Athens, OH 45701, USA.
Bioorg Med Chem Lett. 2025 Mar 1;117:130074. doi: 10.1016/j.bmcl.2024.130074. Epub 2024 Dec 16.
Glycogen synthase kinase-3 (GSK-3) plays a key role in several biochemical pathways and is an attractive target for pharmacological intervention. We prepared a series of analogs of a highly selective thiazolidinethione inhibitor of GSK-3. The structure-activity relationship indicated a precise structural requirement for potent inhibition. We used docking and bioinformatic analysis to explore the rationale for the potency and selectivity of this class of GSK-3 inhibitors. These computational studies identified residues unique to GSK-3 likely to play a role in ligand-specific induced fit interactions. Together, these studies highlight the structural stringency of specific kinase inhibition that can be achieved for GSK-3.
糖原合酶激酶-3(GSK-3)在多种生化途径中起关键作用,是药物干预的一个有吸引力的靶点。我们制备了一系列GSK-3高选择性噻唑烷硫酮抑制剂的类似物。构效关系表明了强效抑制的精确结构要求。我们使用对接和生物信息学分析来探究这类GSK-3抑制剂的效力和选择性的原理。这些计算研究确定了GSK-3特有的残基,这些残基可能在配体特异性诱导契合相互作用中发挥作用。总之,这些研究突出了可实现的针对GSK-3的特定激酶抑制的结构严格性。